Inhibiting GS-FDH to modulate NO bioactivity

Details Inhibiting GS-FDH to modulate NO bioactivity Inhibiting GS-FDH to modulate NO bioactivity

2007-02-20

2007-02-20

Tsang, Cecilia (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S021800, C514S470000, C514S474000, C514S824000, C424S043000, C424S451000, C424S452000, C424S456000, C424S484000

Reexamination Certificate

active

09757610

ABSTRACT:
Patients needing NO donor therapy or inhibition of pathologically proliferating cells or increased NO bioactivity are treated with a therapeutically effective amount of an inhibitor of glutathione-dependent formaldehyde dehydrogenase.

REFERENCES:
patent: 5648393 (1997-07-01), Stamler et al.
patent: 6057367 (2000-05-01), Stamler et al.
patent: 6159500 (2000-12-01), Demopoulos et al.
patent: 6204248 (2001-03-01), Demopoulos et al.
patent: 2001/0012834 (2001-08-01), Stamler
Gura, Science, Nov. 7, 1997 “Systems for indentifying new drugs are often faulty” vol. 278, pp. 1041-1042.
Dermer, “Another Anniversary for the War on Cancer”, 1994, Bio/Technology, vol. 12, pp. 320.
Jensen, D. E., et al., Biochemical Pharmacology 53, 1297-1305 (1997).
Liu, L., et al., Nature 410, 490-494 (Mar. 22, 2001).
Jensen, D. E., et al., Biochem. J. 331, 659-668 (1998).
Kuwada, M., et al., J. Biochem. 88, 859-869 (1980).

Affiliated with

Also associated with

Rating

Inhibiting GS-FDH to modulate NO bioactivity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibiting GS-FDH to modulate NO bioactivity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibiting GS-FDH to modulate NO bioactivity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3868145